Author Information
David Shu Cheong Hui is a distinguished expert in the field of respiratory medicine and infectious diseases, affiliated with the Division of Respiratory Medicine and the Stanley Ho Center for Emerging Infectious Diseases at The Chinese University of Hong Kong, Prince of Wales Hospital, located in the Hong Kong Special Administrative Region, China. His work primarily focuses on the study and management of respiratory illnesses and emerging infectious diseases.Research Contributions
David Shu Cheong Hui has made significant contributions to the understanding and management of respiratory diseases, particularly in the context of infectious diseases like SARS-CoV-2. His research has explored various aspects of COVID-19, including immune responses, diagnostic methods, and treatment options. Notable studies include the assessment of neutralizing antibody titres in SARS-CoV-2 infections, the evaluation of different diagnostic sample collection methods, and the exploration of potential therapeutic agents against the virus. Beyond COVID-19, his work also addresses the intersection of respiratory conditions with metabolic diseases, exemplified in his research on obstructive sleep apnea and its treatments.Aliases
David Shu Cheong Hui is known by several aliases in the academic community, reflecting variations in the presentation of his name across publications. Some of these aliases include David S. Hui, David Sc Hui, David Shu-cheong Hui, and David S.c. Hui, among others.Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
212 |
| Total Citations |
40,206 |
| h-index |
56 |
